Martin Rabel, PhD

Services Solution Specialist at Cytiva

Speaker

Martin Rabel, Ph.D., is commercially responsible for Cytiva's BioPharma Services portfolio in EMEA/APAC. He enables nucleic acid-based therapy projects using Cytiva's proprietary lipid nanoparticle (LNP) platform and value-added nanoparticle development, analytical, and cGMP-compliant manufacturing services. He is involved in developing, shaping, and growing this new addition to Cytiva's product portfolio. Combining his expertise as a Pharmacist with his technical knowledge of nanomedicine and RNA-LNPs, Martin strives to deliver exceptional customer support, scientific and commercial excellence.